Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Clinical trial NCT00491985 · COMPLETED

Trial details

NCT number: NCT00491985
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Orthomyxoviridae Infections Influenza A Virus Infection

Start date: 2007-06-01
Primary completion: 2009-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.